NCT07596901RecruitingPhase 1/2
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients With Generalized Myasthenia Gravis
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
This clinical study will enroll patients with generalized myasthenia gravis (gMG). The goal of this clinical study is to assess the safety, tolerability, effectiveness, pharmacokinetics (how the body processes the drug) and pharmacodynamics (how the drug affects the body) of aritinercept.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 81 (estimated)
- First submitted
- 13 May 2026
- Start date
- 22 Apr 2026
- Primary completion date
- 2 Mar 2029
- Lead sponsor
- Aurinia Pharmaceuticals Inc.
- Diseases
- Myasthenia gravis
- NCT number
- NCT07596901
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 81
- From 22 Apr 2026 to the primary completion date, 2 Mar 2029
- 10 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Current or medical history of malignancy within the last 5 years
Other
- Pregnant, breastfeeding or intending to become pregnant during the Study
- Additional exclusion criteria are defined in the protocol
Who the study is looking for
- Adult patients (18-85 years old)
- Myasthenia Gravis Foundation of America (MGFA) Class II-IV gMG
- Additional inclusion criteria are defined in the protocol
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aurinia Investigational Site Coordinator of this site? Confirm its status | Altamonte Springs | United States | Recruiting |
| Aurinia Investigational Site Coordinator of this site? Confirm its status | Boca Raton | United States | Recruiting |
| Aurinia Investigational Site Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
| Aurinia Investigational Site Coordinator of this site? Confirm its status | Dearborn | United States | Recruiting |
| Aurinia Investigational Site Coordinator of this site? Confirm its status | Flint | United States | Recruiting |
| Aurinia Investigational Site Coordinator of this site? Confirm its status | Homestead | United States | Recruiting |
| Aurinia Investigational Site Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
| Aurinia Investigational Site Coordinator of this site? Confirm its status | Miami | United States | Recruiting |
| Aurinia Investigational Site Coordinator of this site? Confirm its status | O'Fallon | United States | Recruiting |
| Aurinia Investigational Site Coordinator of this site? Confirm its status | Pasadena | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.